You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atezolizumab

Showing 26 - 50 of 308
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor, Solid Trial in United States (BDB001, Atezolizumab)

Active, not recruiting
  • Tumor, Solid
  • Los Angeles, California
  • +4 more
Jul 6, 2022

Small Cell Lung Cancer Recurrent Trial in Goyang-si (Atezolizumab)

Recruiting
  • Small Cell Lung Cancer Recurrent
  • Atezolizumab
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Urothelial/Bladder Cancer, Nos Trial in New York (Atezolizumab, PGV001, Poly ICLC)

Completed
  • Urothelial/Bladder Cancer, Nos
  • Atezolizumab
  • +3 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 7, 2022

Non Small Cell Lung Cancer Trial in Durham (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Durham, North Carolina
    Duke University Medical Center
May 23, 2022

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Atezolizumab
  • +4 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Hepatocellular Carcinoma Trial in Korea, Republic of, United States (SRF388, Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Duarte, California
  • +3 more
Aug 15, 2022

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023

Colorectal Cancer Trial in Essen (Atezolizumab)

Recruiting
  • Colorectal Cancer
  • Atezolizumab
  • Essen, Germany
    Westdeutsches Tumorzentrum
Feb 14, 2022

Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Oral Cavity Squamous Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Frankfurt, Bern (Atezolizumab, 5-Fluorouracil, Calciumfolinat)

Active, not recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Atezolizumab
  • +4 more
  • Frankfurt, Germany
  • +1 more
Apr 14, 2022

NSCLC Stage IV, NSCLC, Recurrent Trial in Fairway, Kansas City (Atezolizumab)

Not yet recruiting
  • NSCLC Stage IV
  • NSCLC, Recurrent
  • Atezolizumab
  • Fairway, Kansas
  • +1 more
Jan 20, 2022

Endometrial Cancer Trial in Birmingham, Saint Louis, Oklahoma City (Bevacizumab, Atezolizumab)

Active, not recruiting
  • Endometrial Cancer
  • Birmingham, Alabama
  • +2 more
Feb 21, 2022

Invasive Bladder Cancer Trial in Madrid (Atezolizumab, BCG)

Recruiting
  • Invasive Bladder Cancer
  • Madrid, Spain
    Hospital 12 de Octubre
Feb 8, 2022

Advanced Solid Tumors, Metastatic Solid Tumors Trial in Duarte, Cheongju-si (GDC-1971, Atezolizumab, Omeprazole)

Recruiting
  • Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Duarte, California
  • +1 more
Aug 10, 2022

NSCLC Stage IV Trial in Bellinzona, Chur, Geneva (Atezolizumab)

Recruiting
  • NSCLC Stage IV
  • Atezolizumab
  • Bellinzona, Switzerland
  • +2 more
Apr 26, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Essen (Atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Atezolizumab
  • Essen, Germany
    University Hospital Essen
Oct 6, 2021

NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Atezolizumab
  • +5 more
  • (no location specified)
Jan 18, 2023

Solid Tumor, Metastatic Cancer Trial in United States (TJ004309, Atezolizumab)

Active, not recruiting
  • Solid Tumor
  • Metastatic Cancer
  • Birmingham, Alabama
  • +3 more
Mar 31, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Houston (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Hepatocellular Cancer
  • Houston, Texas
    Houston Methodist Research Institute
Jan 5, 2022

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Abemaciclib, Atezolizumab)

Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 20, 2021

Squamous Cell Carcinoma of Head and Neck Trial in Aurora, Colorado Springs, Highlands Ranch (Atezolizumab, Stereotactic Body

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Atezolizumab
  • Stereotactic Body Radiation Therapy
  • Aurora, Colorado
  • +3 more
Jun 15, 2022

Unresectable Hepatocellular Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Chicago, Illinois
  • +4 more
Jul 20, 2022

Unresectable Hepatocellular Carcinoma Trial in Boston (Atezolizumab, Bevacizumab, Stereotactic body radiation therapy (SBRT))

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
  • Atezolizumab
  • +2 more
  • Boston, Massachusetts
  • +2 more
Oct 26, 2021

Tumors Trial in China (Atezolizumab)

Recruiting
  • Neoplasms
  • Atezolizumab
  • Beijing, China
  • +8 more
Aug 18, 2022

Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Atezolizumab
  • +2 more
  • San Francisco, California
  • +1 more
Feb 14, 2022